Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 25, 2022, IO Biotech, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). Two items of business were acted upon by the stockholders at the Annual Meeting. The final results for the votes regarding each proposal are set forth below.

Proposal One: Election of Class I Directors

Each of Jack B. Nielsen and David V. Smith was elected to serve as a class I director to hold office until the Company's 2025 Annual Meeting of Stockholders and until the election and qualification of his successor. Votes were cast as follows:



                      For          Withheld      Broker Non-Votes
Jack B. Nielsen     22,460,202       938,718               320,057
David V. Smith      23,387,185        11,735               320,057

Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm

The stockholders ratified the appointment of EY Godkendt Revisionspartnerselskab as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 by the following vote:



   For       Against   Abstain   Broker Non-Votes
23,707,581   10,261     1,136           -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses